Evolocumab for early reduction of LDL-C levels in patients with acute ischemic stroke: a randomized controlled trial

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2024-12-23
DOI
https://doi.org/10.3389/fneur.2024.1454608
Citations
1
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolocumab for early reduction of LDL-C levels in patients with acute ischemic stroke: a randomized controlled trial

Mengru Lu, Junli Liang, Shiting Tang, Yujia Mei et al.
1 citations
Frontiers in Neurology
Lipoproteins and Cardiovascular Health
0.57
article

Evolocumab for early reduction of LDL-C levels in patients with acute ischemic stroke: a randomized controlled trial

Mengru Lu, Junli Liang, Shiting Tang, Yujia Mei, Jinyu Liang, Xiaohui Qiu, Yunfei Wei, Yeyuan Liang, Jian Tang
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in NeurologyVol. 15
Guangxi Medical University (CN)
Good health and well-being
Openalex Percentile: Top 26%
Lipoproteins and Cardiovascular Health
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.